Gram-positive Inhibitor
Gram-positive Inhibitor - Related Videos
01:23
Inhibitors of Gram-positive Cell Wall Synthesis
0 Views •
2026
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
09:10
Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
0 Views •
2022
A detailed protocol is presented for preparing the bacteriostatic diamide masarimycin, a small molecule probe that inhibits the growth of Bacillus subtilis and Streptococcus pneumoniae by targeting cell wall degradation. Its application as a chemical probe is demonstrated in synergy/antagonism assays and morphological studies with B. subtilis and S. pneumoniae.
03:13
Generating Protoplasts from the Gram-Positive Bacterium Bacillus megaterium
0 Views •
2025
Source: Figueroa, D. M., et al. Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization. J. Vis. Exp. (2018)This video demonstrates a step-by-step procedure for generating protoplasts from the Gram-positive bacterium Bacillus megaterium.
05:35
A Broth Microdilution Method for Antibiotic Susceptibility Testing of Gram-Positive Bacteria
0 Views •
2025
Source: Koeth, L. M., et. al., A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically. J. Vis. Exp. (2015).This video demonstrates the broth microdilution method for determining the minimum inhibitory concentration (MIC) of a lipoglycopeptide antibiotic against Gram-positive bacteria. It covers bacterial colony isolation, dilution, inoculation of microplate wells with varying antibiotic concentrations, and verification of culture...
08:34
MS2-Affinity Purification Coupled with RNA Sequencing in Gram-Positive Bacteria
0 Views •
Cited by 10 •
2021
MAPS technology has been developed to scrutinize the targetome of a specific regulatory RNA in vivo. The sRNA of interest is tagged with a MS2 aptamer enabling the co-purification of its RNA partners and their identification by RNA sequencing. This modified protocol is particularly suited for Gram-positive...
FAQs
The principal targets include peptidoglycan synthesis, membrane integrity, ribosomal protein production, and metabolic enzyme activity. Disrupting these processes can interfere with cell-wall construction, membrane function, protein production, or essential metabolism. Identifying the affected process helps researchers connect an observed growth-suppressing effect with a plausible biochemical mechanism of action.
A thick, exposed peptidoglycan cell wall provides an important structural feature for understanding how inhibitory compounds or biological agents affect Gram-positive bacteria. Because the wall is closely associated with cell survival and peptidoglycan synthesis is a recognized target, studying this layer can help relate antimicrobial activity to cell-envelope disruption and biochemical targeting.
Inhibition linked to peptidoglycan synthesis suggests interference with cell-wall construction, whereas effects on membrane integrity point to damage or loss of membrane function. Changes in ribosomal protein production implicate protein synthesis, while altered metabolic enzyme activity suggests disruption of essential metabolism. These distinctions support more precise mechanism-of-action studies.
Characterizing which processes are affected and how strongly bacterial growth is suppressed provides information for monitoring antimicrobial activity over time. Growth inhibition assays, minimum inhibitory concentration measurements, and biochemical target studies can be combined to compare inhibitor responses and investigate changes relevant to resistance surveillance. This work also supports antibiotic discovery and mechanism-focused research.
A growth inhibition assay shows whether exposure to a compound or biological agent suppresses bacterial growth under the tested conditions. It provides an initial functional assessment before researchers examine biochemical targets in greater detail. Results from this type of assay can help identify candidates for further characterization against Gram-positive organisms.
Minimum inhibitory concentration measurements provide a concentration-based way to characterize how much inhibitor is associated with suppression of bacterial growth. Used alongside growth inhibition assays, they help organize antimicrobial activity into a more comparable experimental result. Researchers can then relate that activity to biochemical target studies and broader antibiotic discovery efforts.
Biochemical target studies are especially valuable when researchers need to move beyond observing growth suppression and determine which essential process is affected. Examining peptidoglycan synthesis, membrane integrity, ribosomal protein production, or metabolic enzyme activity can clarify the mechanism of action. Such information supports inhibitor development and research on Staphylococcus and Streptococcus infections.